General Information of the Compound
| Compound ID |
CP0477795
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[(2R,5R)-1-benzhydryl-5-methyl-4-(4-methylphenyl)sulfonylpiperazin-2-yl]butoxy-tert-butyl-dimethylsilane
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H50N2O3SSi
|
||||||||||||||||||
| Molecular Weight |
606.949
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CN(C(c2ccccc2)c2ccccc2)[C@H](CCCCO[Si](C)(C)C(C)(C)C)CN1S(=O)(=O)c1ccc(C)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H50N2O3SSi/c1-28-21-23-33(24-22-28)41(38,39)37-27-32(20-14-15-25-40-42(6,7)35(3,4)5)36(26-29(37)2)34(30-16-10-8-11-17-30)31-18-12-9-13-19-31/h8-13,16-19,21-24,29,32,34H,14-15,20,25-27H2,1-7H3/t29-,32-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PQGSCTPCRFEKHE-QLWXXVCSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04580, Voltage-dependent L-type calcium channel subunit alpha-1C
Protein ID: PT02836, Voltage-dependent N-type calcium channel subunit alpha-1B